Immunotec Inc.

Immunotec Inc.

July 15, 2013 16:09 ET

Immunotec Announces A Corporate Update

VAUDREUIL-DORION, QUEBEC--(Marketwired - July 15, 2013) - Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the wellness industry (the "Corporation" or "Immunotec") announced today that Mr. Robert Henry has tendered his resignation as a director of Immunotec.

At a meeting of its board of directors (the "Board") held on this date, the Board accepted Mr. Henry's resignation and cancelled the special meeting of the shareholders of Immunotec which had been scheduled to be held on August 15, 2013 for the purpose of removing Mr. Henry from the Board.

About Immunotec Inc.

Immunotec is a world-class business opportunity supported by unique, scientifically proven products that improve wellness. Headquartered with manufacturing facilities near Montreal, Canada, the Corporation also has distribution capacities to support its commercial activities in Canada and internationally to the United States, Mexico, Europe and the Caribbean.

The Corporation files its consolidated financial statements, its management and discussion analysis report, its press releases and such other required documents on the SEDAR database at and on the Corporation's website at The Shares are listed on the TSX Venture Exchange under the ticker symbol IMM.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in this news release are forward-looking and are subject to numerous risks and uncertainties, known and unknown. For information identifying known risks and uncertainties and other important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the heading Risks and Uncertainties in Immunotec's most recent Management's Discussion and Analysis, which can be found at Consequently, actual results may differ materially from the anticipated results expressed in these forward-looking statements.

Contact Information

  • Immunotec Inc.
    Patrick Montpetit
    Chief Financial Officer
    (450) 510-4527